Most Read

  • MLA announces launch of Cape Town office
    Moonyeenn Lee & Associates (MLA), now the largest talent agency on the African continent, has announced that it is opening a new office in Cape Town. The launch of a representative office in the heart of one of South Africa's premier film destinations follows fast on the heels of a recent announcement that the agency would be representing screenwriters and directors alongside the leading talent already in the stable. Issued by Moonyeenn Lee & Associates (MLA)
  • Kaya 959 gives away R1,000 an hour every hour in May
    After 12 years of being 'The Home of the Afropolitan', we are excited to introduce our latest evolution - Kaya 959. On the Street. On the Air. Our new brand identity is about highlighting Kaya 959 as a radio station for all. Issued by KAYA 959
  • Kantar announces South Africa's top 10 Best Liked Ads for Q3 and Q4 2020
    Kantar's Best Liked Ads celebrates South Africa's favourite TV commercials. These are the ads that have been rated as the best liked by the South African audience, who we believe to be the most important critic - the person who ultimately chooses to buy your brand or not. Issued by Kantar
Show more

Africa

More...Submit news

Sahpra recommends lifting the J&J vaccine suspension

The South African Health Products Regulatory Authority (Sahpra) has recommended the pause on the rollout of the Johnson & Johnson (J&J) vaccine be lifted.
The country's health department put the J&J vaccine on hold, after the US’ Food and Drug Administration paused the vaccine after reports of six women, out of 6.6-milion doses administered, developed rare cerebral venous thrombosis, with low blood levels of blood platelets.

SA temporarily suspends J&J jab

The South African Department of Health has put the Johnson & Johnson Covid-19 vaccine on hold temporarily, while it investigates a possible link between the jab and a rare blood clot disorder...

14 Apr 2021



Sahpra said in a statement that it had engaged with the J&J’s Sisonke phase 3B implementation study team and Janssen Pharmaceutica to discuss the safety of the vaccines as well as the adverse findings reported in the US.

“Based on their review of the available data, Sahpra has recommended that the pause in the Sisonke study be lifted, provided that specific conditions are met.”

Healthcare workers participating in the Sisonke study will also be informed about the possible risks of developing a blood clotting disorder after vaccination.

“They will also be advised to seek immediate medical assistance if they develop early signs and symptoms associated with blood clots or low platelet counts. The study team will submit the required updated documents, procedures and study arrangements to Sahpra for approval.”
Comment

Related

News

Let's do Biz